Compare RELL & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RELL | IXHL |
|---|---|---|
| Founded | 1947 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Electronic Components | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.6M | 134.7M |
| IPO Year | N/A | N/A |
| Metric | RELL | IXHL |
|---|---|---|
| Price | $10.61 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.5K | ★ 9.8M |
| Earning Date | 01-07-2026 | 02-13-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | ★ 71.90 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $212,588,000.00 | $12,000.00 |
| Revenue This Year | $4.72 | N/A |
| Revenue Next Year | $14.93 | N/A |
| P/E Ratio | $190.10 | ★ N/A |
| Revenue Growth | ★ 4.74 | N/A |
| 52 Week Low | $7.57 | $0.08 |
| 52 Week High | $13.88 | $2.25 |
| Indicator | RELL | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 49.09 |
| Support Level | $9.75 | $0.38 |
| Resistance Level | $10.83 | $0.41 |
| Average True Range (ATR) | 0.44 | 0.02 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 40.31 | 37.46 |
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.